Primary Record
Onvansertib
- In stock
- 975 g
- Purity
- 99.2 %
- CAS
- 1034616-18-6
Compound Identifiers & Properties
- CAS
- 1034616-18-6
- PubChem CID
- 49792852
- SMILES
- CN1CCN(CC1)C2=CC(=C(C=C2)OC(F)(F)F)NC3=NC=C4CCC5=C(C4=N3)N(N=C5C(=O)N)CCO
- Canonical SMILES
- CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1
Names & Synonyms
- Onvansertib
- NMS-1286937
- 1034616-18-6
- NMS-P937
- Onvansertib free base
- Onvansertib [USAN]
- Onvansertib (USAN)
- 67RM91WDHQ
- PCM-075
- UNII-67RM91WDHQ
- RefChem:928230
- ONVANSERTIB [INN]
- D0AN4K
- NMS-P937 (NMS1286937)
- Onvansertib (NMS-P937)
- CHEMBL1738758
- ONVANSERTIB [WHO-DD]
- 'PLK1 Inhibitor PCM-075
- C24H27F3N8O3
- PLK-1 Inhibitor PCM-075
- MFCD26793840
- QHLVBNKYJGBCQJ-UHFFFAOYSA-N
- DTXSID701025917
- GTPL7918
- NMS P937
- orb1300940
- SCHEMBL1228019
- NMS1286937
- SCHEMBL29379736
- NMS-P 937
- PCM 075
- DTXCID001510165
- GLXC-15790
- HMS3653G04
- HMS3673E21
- AMX10197
- BCP28066
- EX-A1590
- NMS 1286937
- 2590AH
- BDBM50343559
- NSC781344
- NSC800806
- s7255
- WHO 11172
- ZINC43196885
- AKOS027253333
- CCG-269924
- CS-3146
- DB15110
- NSC-781344
- NSC-800806
- SB16941
- NCGC00386361-03
- ONVANSERTIB (NMS-1286937 )
- Polo-like Kinase 1 Inhibitor PCM-075
- AC-36303
- CID:49792852
- DA-66151
- HY-15828
- MS-29838
- NMS-1286937,NMS-P937
- SY311879
- SID:434254322
- 1-(2-Hydroxyethyl)-8-((5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)phenyl)amino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
- B4094
- NMS-P937 (NMS1286937)?
- SW219402-1
- A13045
- D11458
- POLO-LIKE KINASE 1 INHIBITOR NMS-1286937
- 1-(2-hydroxyethyl)-8-[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)anilino]-4,5-dihydropyrazolo[4,3-h]quinazoline-3-carboxamide
- PCM-075;NMS-1286937;NMS-P937
- A896452
- NMS-P937 1034616-18-6
- BRD-K83699324-001-01-1
- Q27087959
- 1-(2-Hydroxyethyl)-8-[[5-(4-Methylpiperazin-1-Yl)-2-(Trifluoromethoxy)phenyl]amino]-4,5-Dihydropyrimido[5,4-G]indazole-3-Carboxamide
- 1H-Pyrazolo(4,3-H)quinazoline-3-carboxamide, 4,5-dihydro-1-(2-hydroxyethyl)-8-((5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl)amino)-
- C000706408
- B1370-462742
- 1-(2-hydroxyethyl)-8-(5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)anilino)-4,5-dihydropyrazolo(4,3-h)quinazoline-3-carboxamide
- 1-(2-HYDROXYETHYL)-8-((5-(4-METHYLPIPERAZIN-1-YL)-2-(TRIFLUOROMETHOXY)PHENYL)AMINO)-4,5-DIHYDRO-1H-PYRAZOLO(4,3-H)QUINAZOLINE-3-CARBOXAMIDE
- 1-(2-hydroxyethyl)-8-(5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
- 1H-Pyrazolo[4,3-h]quinazoline-3-carboxamide, 4,5-dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-;1H-Pyrazolo[4,3-h]quinazoline-3-carboxamide, 4,5-dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-
- 1-(2-Hydroxy-ethyl)-8-[5-(4-methyl-piperazin-1-yl)-2-trifluoromethoxy-phenylamino]-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
- 1-(2-hydroxyethyl)-8-((5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)phenyl)amino)-1H,4H,5H-pyrazolo(4,3-h)quinazoline-3-carboxamide
- 1-(2-Hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
- 1-(2-hydroxyethyl)-8-{[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)phenyl]amino}-1H,4H,5H-pyrazolo[4,3-h]quinazoline-3-carboxamide
- 1-(2-hydroxyethyl)-8-{[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)phenyl]amino}-4H,5H-pyrazolo[4,3-h]quinazoline-3-carboxamide
- 4,5-Dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide